Research Triangle Park, NC, April 25, 2006 --(PR.com
)-- CaraMedica Pharmaceuticals, Inc., an emerging sales, marketing and development company focused on the cosmetic surgery market, announced the national launch of the BioCorneum® product line today. BioCorneum® is a patented, topical, self-drying silicone gel scar treatment which is only available to patients from licensed medical professionals. A spray version of the product will be released in late 2006.
Under a distribution agreement with Seattle-based Advanced Bio-Technologies, Inc, CaraMedica has obtained the exclusive right to market BioCorneum® to cosmetic surgeons and dermatologists in the USA. CaraMedica’s pharmaceutical sales representatives will begin selling BioCorneum® nationwide April 23, 2006.
BioCorneum®, classified by the FDA under a 510(k) as a medical device, manages old and new scars, and prevents the formation of keloids, hypertrophic and atrophic scars resulting from surgery, trauma, burns and skin infections. When applied to the affected area, it suppresses growth factors that lead to scarring, while protecting tissue against physical, chemical and microbial invasion. BioCorneum® rapidly self-dries, offering patients a discreet, effective and convenient way to treat scars.
The launch of the BioCorneum product line marks a milestone for CaraMedica that executives anticipate will bring dramatic and sustained growth for the company. Numbers for the cosmetic surgery industry point to a booming market. According to the American Society for Aesthetic Plastic Surgery, approximately 11.9 million cosmetic procedures were performed in the U.S. in 2004, a 44% increase from the previous year. “CaraMedica is well poised to capitalize on this growth with a portfolio of patented prescription and cosmeceutical products that enable patients to shorten recovery time, accelerate results and extend the benefits of surgery,” commented Damon Race, CEO of CaraMedica.
About CaraMedica Pharmaceuticals Inc.
CaraMedica Pharmaceuticals is an emerging marketing, sales and development company based in Research Triangle Park, North Carolina. CaraMedica offers cosmetic surgeons and dermatologists an exclusive portfolio of patented and proprietary prescription and cosmeceutical products. For more information about CaraMedica, visit http://www.caramedica.com